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Volume 58, Number 2 Harlander-Locke et al 431protrusion into the popliteal vein were not treated with
anticoagulation.However, given the lack of thrombotic com-
plications and PE in our series with this treatment algorithm,
we continue to advocate the use of anticoagulation with level
C and D closures until ultrasound evidence of thrombus
retraction is conﬁrmed.
To our knowledge, this is the largest reported series of
segmental thermal ablation of the SSV using the Closure-
Fast (VNUS Technologies) catheter. Our results demon-
strate that RFA of the SSV can be performed with high
safety and efﬁcacy using the proposed classiﬁcation system
and treatment algorithm for levels of closure at the SPJ.
Anatomic variation of the Giacomini vein and the SPJ
did not inﬂuence levels of closure in this series, but vein
diameter and prior DVT did; further large-scale, multi-
institutional analyses will be required to determine the
signiﬁcance of anatomic variations at the SPJ on levels of
small saphenous ablation.
AUTHOR CONTRIBUTIONS
Conception and design: JJ, PL
Analysis and interpretation: MHL, JJ, PL, BD, DR, HG, SF
Data collection: MHL, JJ
Writing the article: MHL, JJ, PL
Critical revision of the article: JJ, PL, BD, DR, HG, SF
Final approval of the article: JJ, PL
Statistical analysis: MHL, JJ
Obtained funding: Not applicable
Overall responsibility: JJREFERENCES
1. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL,
Gloviczki ML, et al. The care of patients with varicose veins and
associated chronic venous diseases: clinical practice guidelines of the
Society for Vascular Surgery and the American Venous Forum. J Vasc
Surg 2011;53:2S-48S.
2. Samuel N, Wallace T, Carradice D, Shahin Y, Mazari FA, Chetter IC.
Endovenous laser ablation in the treatment of small saphenous varicose
veins: does site of access inﬂuence early outcomes. Vasc Endovascular
Surg 2012;46:310-4.
3. Monahan TS, Belek K, Sarkar R. Results of radiofrequency ablation of
the small saphenous vein in the supine position. Vasc Endovascular
Surg 2012;46:40-4.
4. Kontothanassis D, Di Mitri R, Ferrari Rufﬁno S, Zambrini E,
Camporese G, Gerard JL, et al. Endovenous laser treatment of the
small saphenous vein. J Vasc Surg 2009;49:973-979.e1.5. Gibson KD, Ferris BL, Polissar N, Neradilek B, Pepper D. Endovenous
laser treatment of the small saphenous vein: efﬁcacy and complications.
J Vasc Surg 2007;45:795-801.
6. Gabriel V, Jimenez JC, Alktaiﬁ A, Lawrence PF, O’Connell JB,
Derubertis BG, et al. Success of endovenous saphenous and perforator
ablation in patients with symptomatic venous insufﬁciency on chronic
warfarin therapy. Ann Vasc Surg 2012;26:607-11.
7. Waddell BE, Harkins MB, Lepage PA, Modesto VL, Villavicencio JL.
The crochet hook method of stab avulsion phlebectomy for varicose
veins. Am J Surg 1996;172:278-80.
8. Lawrence PF, Vardanian AJ. Light-assisted stab phlebectomy: report of
a technique for removal of lower extremity varicose veins. J Vasc Surg
2007;46:1052-4.
9. Lin JC, Peterson EL, Rivera ML, Smith JJ, Weaver MR. Vein mapping
prior to endovenous catheter ablation of the great saphenous vein
predicts risk of endovenous heat-induced thrombosis. Vasc Endovas-
cular Surg 2012;46:378-83.
10. Haqqani OP, Vasiliu C, O’Donnell TF, Iafrate MD. Great saphenous
vein patency and endovenous heat-induced thrombosis after endove-
nous thermal ablation with modiﬁed catheter tip positioning. J Vasc
Surg 2011;54:10S-7S.
11. Marsh P, Price BA, Holdstock J, Harrison C, Whiteley MS. Deep vein
thrombosis (DVT) after venous thermoablation techniques: rates of
endovenous heat-induced thrombosis (EHIT) and classical DVT after
radiofrequency and endovenous laser ablation in a single centre. Eur J
Endovasc Surg 2012;40:521-7.
12. Knipp BS, Blackburn SA, Bloom JR, Fellows E, LaForge W, Pfeifer JR,
et al. Endovenous laser ablation: venous outcomes and thrombotic
complications are independent of the presence of deep venous insufﬁ-
ciency. J Vasc Surg 2008;48:1538-45.
13. Suﬁan S, Arnez A, Lakhanpal S. Case of the disappearing heat-induced
thrombus causing pulmonary embolus during ultrasound evaluation.
J Vasc Surg 2012;55:529-31.
14. Mozes G, Kalra M, Carmo M, Swenson L, Gloviczki P. Extension of
saphenous thrombus into the femoral vein: a potential complication of
new endovenous ablation techniques. J Vasc Surg 2005;41:130-5.
15. Ravi R, Rodriguez-Lopez JA, Trayler EA, Barrett DA, Ramaiah V,
Diethrich EB. Endovenous ablation of incompetent saphenous veins:
a large single-center experience. J Endovasc Ther 2006;13:244-8.
16. Lawrence PF, Chandra A, Wu M, Rigberg D, Derubertis B,
Gelabert H, et al. Classiﬁcation of proximal endovenous closure levels
and treatment algorithm. J Vasc Surg 2010;52:388-93.
17. Bisang U, Meier TO, Enzler M, Thalhammer C, Husmann M, Amann-
Vesti BR. Results of endovenous ClosureFast treatment for varicose
veins in an outpatient setting. Phlebology 2012;27:118-23.
18. Nordon I, Hinchliffe RJ, Brar R, Moxey P, Black SA, Thompson M,
et al. A prospective double-blind randomized controlled trial of radi-
ofrequency versus laser treatment of the great saphenous vein in
patients with varicose veins. Ann Surg 2011;254:876-81.
19. Kerver AL, van der Ham AC, Theeuwes HP, Eilers PH, Poublon AR,
Kerver AJ, et al. The surgical anatomy of the small saphenous vein and
adjacent nerves in relation to endovenous thermal ablation. J Vasc Surg
2012;56:181-8.
Submitted Sep 8, 2012; accepted Jan 4, 2013.DISCUSSIONDr Kathleen Gibson (Bellevue, Wash). I would like to thank
the authors for providing the manuscript well in advance of the
meeting. The manuscript adds to existing literature supporting
the success of heat ablation in duplex-documented closure of the
SSV and the freedom from major complications such as nerve
injury or clinically signiﬁcant venous thrombosis. Literature
regarding heat ablation of the SSV has been weighted more heavily
toward laser ablation, and this paper shows that RFA appears to be
safe as well. The objective of the paper was not to address or
measure patient quality of life before or after treatment, but mainly
to evaluate and discuss their algorithm for dealing with EHIT.Eighty limbs were included in the study and patient risk
factors and anatomic variations of the SPJ were recorded preproce-
dure. Duplex-assessed vein closures were classiﬁed as levels A
through D. Patients were examined 24-72 hours postprocedure.
All but one had duplex-veriﬁed closure of the SSV, and only two
out of 80 limbs had a level C occlusion. Both of these patients
were treated with anticoagulation. There were no level D occlu-
sions. Ten patients had level B occlusions, and all of these patients
underwent follow-up duplex scans that showed no progression.
Multivariate analysis of level B and level C occlusions showed
only prior history of DVT and vein diameter greater than 6 mm
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as proposed by my group in our 2007 JVS article had no impact on
level of occlusion.
While I do believe that this paper adds to our existing data
regarding the safety of heat ablation of the SSV, I have the
following critiques:
(1) You included both level B and level C closures in your
multivariate analysis of risk factors. You have shown
that level B closures are benign in your paper, as you
had no progression to an adverse event with observation.
We have seen that in our own practice as well; closures
ﬂush with SPJ do not progress. As such, I would argue
that the level B closures are benign and should not be
included in your multivariate analysis of risk factor for
an adverse event. I suspect that not including them,
and only leaving two adverse events in your series would
make your data set too small to make meaningful obser-
vations about risk of thrombus extensions with heat abla-
tion of the SSV.
(2) I think the anatomic schema that was proposed by our
group at this meeting in 2006 is too vague. Our series
of 210 limbs had a much different breakdown of
anatomic types; 43% had type A anatomy, compared
with your 80%, 33% of our patients had a substantial Gia-
comini branch compared with 15% in your series, and
24% of our patients had no SPJ compared with 5% of
your patients. I think the main problem with the schema
proposed in our paper is the deﬁnition of what constitutes
a major saphenopopliteal branch, which is not well
deﬁned by either paper.
(3) You show that with your treatment algorithm of the two
patients with thrombus extension, the patients did well and
the thrombus resolved. What we do not know and what
no paper that I know of has shown us is if these patients
would have done well with no treatment whatsoever. Our
main goal is the avoidance of life-threatening complications
such as PE, and given there is no control group that is not
treated, we do not know if your algorithm is protective.
Questions:
(1) You noted in your manuscript that the diameter of the
SSV was a signiﬁcant risk factor for the development of
an EHIT. Diameter of the SSV can vary greatly depending
on patient positioning and location measured. Can you
describe the technique used for scanning patients in
your lab in terms of positioningeare the patients scanned
while standing? What location of the SSV was used in your
database? The largest diameter? The SPJ?(2) You rescanned the patients with a “level B” closure to
rule out progression of thrombus in the popliteal vein
and found that in 10/10 patients, there was no progres-
sion. As a result of this study, are you no longer following
these patients with serial scans? If not, why?
(3) In your classiﬁcation scheme, there were no patients with
level D thrombus extension into the SSV and only two
patients with any thrombus extension into the SSV (level
C). Can you give us more information about these two
patients? How far did the thrombus extend into the
deep vein? Was it merely a bulge or adherent to the
deep vein wall? As in most series describing the treatment
of EHIT, there is no comparison, or nontreatment
group. With your algorithm, all of the thrombus exten-
sions resolved with treatment, and there appeared to be
no complications from anticoagulation. Are there any
“level C” thrombus extensions that you would believe
comfortable observing rather than treating?
Dr Juan Carlos Jimenez. Dr Gibson, thanks very much for
your excellent questions. In response to the positioning of the
patient during ultrasound examinations, all our patients are
scanned in the standing position under similar environmental
conditions. We used the largest diameter measured along the
entire SSV in the lower leg. We did note that the largest diameter
of the SSV in these patients was the SPJ.
Following the initial postoperative scan 24-72 hours following
the small saphenous ablation, we obtain serial duplex scans for the
following indications. One is to track the progression of EHIT for
patients with closures ﬂush to the SPJ or extension of thrombus
into the popliteal vein. In our series, serial scans were performed until
radiographic evidence of thrombus retraction into the SSV was
demonstrated. Patients who returned at a later time with recurrence
of symptoms are also rescanned. Our rationale for not retesting
asymptomatic patients following great saphenous vein or SSV abla-
tion is that these patients are not candidates for further invasive treat-
ment regardless of vein patency. Only symptomatic patients
demonstrating axial reﬂux are treatedwith ablation at our institution.
As for the two patients with thrombus extension into the popli-
teal vein, both had signiﬁcant EHIT protrusion into the deep
venous system and required 13 and 36 days of treatment with love-
nox until the thrombus retracted. They were both at risk for further
extension into the deep venous system if left untreated. Although
serious thromboembolic complications are rare following these
procedures, we have noted one pulmonary embolus following great
saphenous ablation. Thus, at this point in our experience, we still
believe therapeutic anticoagulation following EHIT extension
into the deep venous system following radiofrequency saphenous
ablation is the right thing to do.
